文献速递主动脉疾病颈动脉与弓上血管

异常锁骨下动脉病变手术治疗结局的系统评价与Meta分析及建议报告条目

Systematic Review and Meta-Analysis of Outcomes After Operative Treatment of Aberrant Subclavian Artery Pathologies and Suggested Reporting Items.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-02-25

该系统评价与Meta分析汇总1990至2020年间314项研究、732例异常锁骨下动脉病变手术患者,比较开胸/胸骨切开组(A组453例)与无胸部入路血管内/杂交组(B组279例)的结局。A组汇总早期死亡率为1.62%(95%CI 0.05%-4.53%),B组为1.96%(95%CI 0-6.34%);症状缓解率A组99.52%(95%CI 92.05%-100.00%),B组95.79%(95%CI 83.96%-100.00%)。作者结论认为无论采用何种技术,死亡率均很低且临床成功率高,并建议了一套报告条目清单。

要点

  • 314项研究共732例患者,A组开胸/胸骨切开453例,B组无胸部入路血管内/杂交279例。
  • A组汇总早期死亡率1.62%(95%CI 0.05%-4.53%),B组1.96%(95%CI 0-6.34%)。
  • A组汇总症状缓解率99.52%(95%CI 92.05%-100.00%),B组95.79%(95%CI 83.96%-100.00%)。

核心结论

  • 作者结论认为,用于治疗异常锁骨下动脉及累及异常锁骨下动脉的主动脉病变的手术技术,无论采用何种技术,死亡率均很低且临床成功率高。

研究设计与样本

  • 系统检索医学数据库,纳入1990至2020年间报告异常锁骨下动脉病变手术后结局的全部研究。
  • 共纳入314项研究、732例患者(男性60.1%,440/732),分为A组(开胸/胸骨切开开放或杂交手术,453例)与B组(无胸部入路血管内或杂交治疗,279例)。
  • 计算所有关注变量的粗率(CR),并对报告5例及以上患者的研究进行比例Meta分析,报告汇总率及95%CI。

主要发现

  • 证据质量普遍较低,286项研究纳入少于4例患者,28项研究纳入5例及以上病例。
  • 71.4%的患者为左位主动脉弓伴异常右锁骨下动脉,50.1%的病例存在Kommerell憩室。
  • 68%的患者就诊时有症状,其中多数主诉吞咽困难(49.6%)。
  • A组汇总早期死亡率为1.62%(95%CI 0.05%-4.53%),B组为1.96%(95%CI 0-6.34%)。
  • A组汇总症状缓解率为99.52%(95%CI 92.05%-100.00%),B组为95.79%(95%CI 83.96%-100.00%)。

临床怎么用

  • 作者结论认为,无论采用何种技术,治疗异常锁骨下动脉及累及异常锁骨下动脉的主动脉病变的手术技术均与很低的死亡率和很高的临床成功率相关。

局限性

  • 证据质量普遍较低,314项研究中有286项纳入少于4例患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To synthesise and present all available evidence regarding the surgical treatment of patients with aberrant subclavian artery (aSA) pathologies during the last 30 years. The study also aimed to create a checklist of suggested reporting items to help increase reporting homogeneity. METHODS: A systematic search of medical databases was performed to identify all studies published between 1990 and 2020 reporting on the outcomes of patients undergoing surgery for an aSA pathology. Patients were divided into two groups; Group A included patients undergoing open or hybrid surgery through sternotomy/thoracotomy and Group B included patients undergoing endovascular or hybrid treatment without chest access. The % crude rates (CR) of all variables of interest were calculated. A proportion meta-analysis was performed reporting pooled rates with 95% confidence intervals (CIs). RESULTS: Three hundred and fourteen studies were identified reporting on the surgical outcomes of 732 patients (60.1% males; 440/732). The quality of evidence was generally low, with 286 studies including fewer than four patients and 28 studies with five or more cases. Aberrant right subclavian artery (aRSA) in a left sided aortic arch was present in 71.4% of the patients and a Kommerell's diverticulum was present in 50.1% of the cases. A total of 68% of the patients were symptomatic on presentation, with the majority complaining of dysphagia (49.6%). Group A included 453 and Group B 279 patients. Studies reporting on five or more patients were included in the main meta-analysis. The pooled early mortality rate was 1.62% (95% CI 0.05% - 4.53%) in Group A and 1.96% (95% CI 0 - 6.34%) in Group B. Pooled rates of symptom relief were 99.52% (95% CI 92.05% - 100.00%) in Group A and 95.79% (95% CI 83.96% - 100.00%) in Group B. CONCLUSION: The surgical techniques used to treat aSA and aortic pathologies involving an aSA had remarkably low mortality rates and high clinical success, regardless of the technique used.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Konstantinou N, Antonopoulos CN, Tzanis K, et al. Systematic Review and Meta-Analysis of Outcomes After Operative Treatment of Aberrant Subclavian Artery Pathologies and Suggested Reporting Items. Eur J Vasc Endovasc Surg. 2022. PMID: 35459610. doi:10.1016/j.ejvs.2022.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。